Kentucky Statutes 217.5406 – Death of patient receiving experimental treatment absolves heirs of liability for resulting debt
Current as of: 2024 | Check for updates
|
Other versions
If an eligible patient dies while being treated with an investigational drug, biological product, or device, the patient’s heirs are not liable for any outstanding debt related to the treatment or to a lack of insurance as a result of the treatment.
Effective: June 29, 2017
History: Created 2017 Ky. Acts ch. 65, sec. 6, effective June 29, 2017.
Formerly codified as KRS § 217.5411.
Effective: June 29, 2017
Terms Used In Kentucky Statutes 217.5406
- Device: means any instrument or contrivance other than a firearm which is intended for trapping, destroying, repelling, or mitigating any pest or any other form of plant or animal life other than man and other bacteria, virus, or other microorganisms on or in living man or other living animals. See Kentucky Statutes 217.544
- Treatment: when used in a criminal justice context, means targeted interventions
that focus on criminal risk factors in order to reduce the likelihood of criminal behavior. See Kentucky Statutes 446.010
History: Created 2017 Ky. Acts ch. 65, sec. 6, effective June 29, 2017.
Formerly codified as KRS § 217.5411.